Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

WAIT

We are at a critical inflection point. He really likes the chart. He have had some strong volume over the last two days. Wait the next week or two and then it looks good. (Analysts’ price target is $28.00)

WAIT

The problem is that life insurance companies are having a tough time. You are dealing with a tough sector back drop.

DON'T BUY

He has SLF-T in this space. There is resistance at $22 that it has to punch through. It has a lot of resistance to get through. Look at others. See his Top Picks today. (Analysts’ price target is $28.00)

DON'T BUY

This will continue to be a random return opportunity. They earn a lot of money off capital markets returns. They're dealing with the hangover of low interest rates and mispriced products that'll hound them for many years. The street will always give MFC the benefit of the doubt, because they're large capital markets users. MFC isn't doing anything wrong, but are suffering obligations to their policy holders, which they do by selling new obligations in a slow-growing, low-return environment. Instead, look at BNS, RY or TD Bank.

COMMENT

Despite good numbers, the stock price hasn't risen much. He also doesn't understand why it hasn't gone up more. They've done well with Asian growth. Part of the drag comes from their long-term care business in the U.S.; they've reduced their exposire there. But what needs to happen is for MFC to show a couple of solid straight quarters to boost investor confidence.

BUY

Likes it long- and short-term. He'd buy it. A good company. It'll stay in the $18-24 channel, a wide channel.

DON'T BUY

Will it return to $28 within 12 months? He sold it in 2011 and hasn't returned. MFC never fully recovered from the Great Recession. What is their competitive advantage or moat? He prefer Power Corp among Canadian insurers and dividend payers. He avoid this sector, really.

DON'T BUY

Interest rates likely won't rise as high as previously expected. MFC has a history of not great operations in wealth management, lagging the industry. Also, all financial stocks in Canada have sold off. All this won't raise the stock price.

COMMENT

Is China hurting MFC-T? He owned MFC-T going into the 2008 crisis. But when the management announced they had taken on undue risk, he exited. They have never really reemerged from this. They were too exposed to equity markets back then, and decided to exit equities just as the market rallied to all time highs. He thinks there are better opportunities out there -- like SLF-T.

BUY

The short-seller raising the lawsuit is an old issue; he strongly doubts this lawsuit will hurt MFC. MFC is cheaper than its peers, trading at 8x. He sees 8% growth and dividend growth. Their only issue is their John Hancock purchase. They're growing in Asia. Won't hurt you long-term. Very cheap now. He likes it here.

BUY

He is encouraged by the new CEO's moves in the last year. They get a good chunk of earnings form wealth management in Asia. He could potentially add to it in the future.

PAST TOP PICK

(A Top Pick Jan 04/18, Down 20%) Weathered a perfect storm in 2018 including a short seller. Will discuss this in his Top Picks.

TOP PICK

Broader sector rotation into dividend stocks will benefit financials and lifecos. MFC has had a nice bounce off $18 and should perform well this year. He epxects an interest rate increase that will benefit MFC (he doesn't see an inverted yield curve this year). The short-seller allegations against them were really tenuous and should be resolved soon. MFC is trading at book value and pays a nearly 5% dividend. (Analysts’ price target is $28.25)

PAST TOP PICK

(A Top Pick Jan 23/18, Down 20%) A disappointment, but so have all the insurers. Trading at a "buy" valuation. Would buy for new clients. Manulife is exposed to Asian economy, which is slowing, so there may be an opportunity to buy when the fourth quarter reports. Extremely well capitalized. May see disposal of assets. Lots of strength going forward.

BUY

He has a target price of $31 on it. It is frustrating. There are fears for their business with China; fears of higher interest rates; fears of MFC-T changing it policy. When you build a fortress balance sheet your growth comes down. Eventually the market will catch on to its strong points. 5% yield vs. 4.4% on SLF-T as it has a higher perceived risk, being stuck in Canada.

Showing 421 to 435 of 2,279 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)